These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15710807)

  • 1. A correct evaluation of renal function could decrease bleeding risk in anticoagulated elderly patients.
    Antón E
    Arch Intern Med; 2005 Feb; 165(3):349-50; author reply 350. PubMed ID: 15710807
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of LMW heparin: information for prescribers. Update: 10 April 2002].
    Agence Française de Sécurité Sanitaire Des Produits de Santé (AFSSAPS)
    J Mal Vasc; 2002 Oct; 27(4):231-3. PubMed ID: 12457130
    [No Abstract]   [Full Text] [Related]  

  • 3. LMWH and renal failure: bleeding. Creatinine clearance should be checked before choosing heparin products.
    Prescrire Int; 2007 Dec; 16(92):251. PubMed ID: 18092423
    [No Abstract]   [Full Text] [Related]  

  • 4. Excessive anticoagulation in patients with mild renal insufficiency receiving long-term therapeutic enoxaparin.
    Busby LT; Weyman A; Rodgers GM
    Am J Hematol; 2001 May; 67(1):54-6. PubMed ID: 11279659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is establishing an appropriate bleeding risk profile in elderly patients treated with low-molecular-weight heparins needed?
    Anton E; Marti J
    J Am Geriatr Soc; 2005 Oct; 53(10):1834-5; author reply 1835-6. PubMed ID: 16181193
    [No Abstract]   [Full Text] [Related]  

  • 6. [A contribution safety on using low molecular weight heparin in patients with renal failure].
    Gea Rodríguez E; Barral Viñals N; Manso Mardones P; Indo Berges O
    Farm Hosp; 2004; 28(2):101-5. PubMed ID: 15101801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight heparin and bleeding in patients with chronic renal failure.
    Crowther M; Lim W
    Curr Opin Pulm Med; 2007 Sep; 13(5):409-13. PubMed ID: 17940486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of LMWH in renal failure.
    Bernheim J; Benchetrit S
    Isr Med Assoc J; 2005 Dec; 7(12):822; author reply 823. PubMed ID: 16385768
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of venous thromboembolism after acute spinal cord injury with low-dose heparin or low-molecular-weight heparin.
    Paciaroni M; Ageno W; Agnelli G
    Thromb Haemost; 2008 May; 99(5):978-80. PubMed ID: 18449438
    [No Abstract]   [Full Text] [Related]  

  • 10. Does a longer duration of oral factor Xa therapy increase the risk of bleeding or transaminitis?
    From AM; Hoganson DD; Erwin PJ
    Thromb Res; 2011 Mar; 127(3):202-9. PubMed ID: 21159363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronically anticoagulated patients who need surgery: can low-molecular-weight heparins really be used to "bridge" patients instead of intravenous unfractionated heparin?
    Jaff MR
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S17-21. PubMed ID: 19213061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism in patients with intracranial haemorrhage.
    Lobo JL; Nieto JA; Zorrilla V; Garrido N; Madridano O; Ruiz J; Farge-Bancel D; Tiberio G; Uresandi F; Monreal M;
    Thromb Haemost; 2011 Oct; 106(4):750-2. PubMed ID: 21901229
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticoagulants for thrombosis prophylaxis following surgery: a continuing saga.
    Caprini JA
    Thromb Haemost; 2008 Jun; 99(6):993-4. PubMed ID: 18521498
    [No Abstract]   [Full Text] [Related]  

  • 14. [Low molecular weight heparin and hemorrhagic risk in elderly patients].
    Franco A
    Rev Med Interne; 2001 Feb; 22(2):118-9. PubMed ID: 11234668
    [No Abstract]   [Full Text] [Related]  

  • 15. [Initial results of the PROTECT Study publicized. Stroke patients need effective thrombosis prevention].
    Diener HC
    MMW Fortschr Med; 2005 Jun; 147(22):50. PubMed ID: 15977636
    [No Abstract]   [Full Text] [Related]  

  • 16. Perioperative bridging therapy for the at-risk patient on chronic anticoagulation.
    Spyropoulos AC
    Dis Mon; 2005; 51(2-3):183-93. PubMed ID: 15900271
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings.
    Nutescu EA; Spinler SA; Wittkowsky A; Dager WE
    Ann Pharmacother; 2009 Jun; 43(6):1064-83. PubMed ID: 19458109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal retroperitoneal haemorrhage associated with enoxaparin and impaired renal function.
    Quiles J; Avanzas P; Bueno H
    Int J Cardiol; 2005 Feb; 98(3):523-4. PubMed ID: 15708194
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal failure and low molecular weight heparins. A dangerous liaison? The case of retroperitoneal hematoma.
    Kravitz MS; Mishaal RA; Shoenfeld Y
    Isr Med Assoc J; 2005 Sep; 7(9):600-1. PubMed ID: 16190487
    [No Abstract]   [Full Text] [Related]  

  • 20. The safety of heparins in end-stage renal disease.
    Sonawane S; Kasbekar N; Berns JS
    Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.